Claim · 2022-09-20 · publication · Stated in source · Supported

NVIDIA announced on 20 September 2022 (GTC) the NVIDIA BioNeMo LLM Service, a cloud API "to accelerate drug discovery for pharma and biotech companies", stating that it was "expected to be available in early access starting next month".

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biology → states provision → NVIDIA announced the BioNeMo LLM Service, expected in early access the following month

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biologystates provision ↓NVIDIA announced the BioNeMo LLM Service, expected in early access the following month

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Provision: Statement · provision ID labs-nv-bionemo-announced-2022
Date: 2022-09-20 · publication Records dated 2022 →

Scope and limitsAn announced product with expected availability, not evidence that it became available on that schedule or of its effect on drug discovery; the release carries NVIDIA's own forward-looking-statements caution.

The evidence 02

primary sourceSupports the claim

NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biology

NVIDIA · 2022-09-20

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“The NVIDIA BioNeMo Service is a cloud application programming interface (API) that expands LLM use cases beyond language and into scientific applications to accelerate drug discovery for pharma and biotech companies.”

Location in source paragraph 2

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: NVIDIA
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 bad97a72ca1b71e8672a87ee1430090695e6a220fdce005df592a2a9ebb9fe36). NVIDIA Newsroom release dated September 20, 2022, as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: NVIDIA, “NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biology”, 2022-09-20.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (31 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

primary sourceSupports the claim

NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biology

NVIDIA · 2022-09-20

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“The NeMo LLM and BioNeMo services and cloud APIs are expected to be available in early access starting next month.”

Location in source availability paragraph

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: NVIDIA
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 bad97a72ca1b71e8672a87ee1430090695e6a220fdce005df592a2a9ebb9fe36). NVIDIA Newsroom release dated September 20, 2022, as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: NVIDIA, “NVIDIA Launches Large Language Model Cloud Services to Advance AI and Digital Biology”, 2022-09-20.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (20 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.

Date. Dated by the release. The record is dated by the text’s date of publication, which is the date of its announcement.

Record ID aib-labs-nv-bionemo-announced-2022